Serveur d'exploration Tocilizumab - Exploration (Accueil)

Index « Mesh.i » - entrée « Drug Therapy, Combination »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Drug Therapy < Drug Therapy, Combination < Drug Tolerance  Facettes :

List of bibliographic references indexed by Drug Therapy, Combination

Number of relevant bibliographic references: 249.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000258 (2020) Peter N. Taylor [Royaume-Uni] ; Lei Zhang [Royaume-Uni] ; Richard W J. Lee [Royaume-Uni] ; Ilaria Muller [Royaume-Uni] ; Daniel G. Ezra [Royaume-Uni] ; Colin M. Dayan [Royaume-Uni] ; George J. Kahaly [Allemagne] ; Marian Ludgate [Royaume-Uni]New insights into the pathogenesis and nonsurgical management of Graves orbitopathy.
000634 (2019) Ariane Klein [Allemagne][Biologics in the treatment of juvenile idiopathic arthritis : A comparison of mono- and combination therapy with synthetic DMARDs].
000653 (2019) Lianne Kearsley-Fleet [Royaume-Uni] ; Sunil Sampath [Royaume-Uni] ; Liza J. Mccann [Royaume-Uni] ; Eileen Baildam [Royaume-Uni] ; Michael W. Beresford [Royaume-Uni] ; Rebecca Davies [Royaume-Uni] ; Diederik De Cock [Royaume-Uni] ; Helen E. Foster [Royaume-Uni] ; Taunton R. Southwood [Royaume-Uni] ; Wendy Thomson [Royaume-Uni] ; Kimme L. Hyrich [Royaume-Uni]Use and effectiveness of rituximab in children and young people with juvenile idiopathic arthritis in a cohort study in the United Kingdom.
000682 (2019) Sisi Cai ; Zhaodong Zhong ; Xiang Li [République populaire de Chine] ; Hong Xiang Wang [République populaire de Chine] ; Li Wang [République populaire de Chine] ; Min ZhangTreatment of multicentric Castleman disease through combination of tocilizumab, lenalidomide and glucocorticoids
000724 (2019) Levente Bodoki [Hongrie] ; Edit Végh [Hongrie] ; Zoltán Szekanecz [Hongrie] ; Gabriella Sz Cs [Hongrie]Tocilizumab Treatment in Polyarteritis Nodosa.
000813 (2019) Sara Monti [Italie] ; Ana F. Águeda [Portugal] ; Raashid Ahmed Luqmani [Royaume-Uni] ; Frank Buttgereit [Allemagne] ; Maria Cid [Espagne] ; Christian Dejaco [Italie, Autriche] ; Alfred Mahr [France] ; Cristina Ponte [Portugal] ; Carlo Salvarani [Italie] ; Wolfgang Schmidt [Allemagne] ; Bernhard Hellmich [Allemagne]Systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis: focus on giant cell arteritis
000831 (2019) Laura Bazzichi [Italie] ; Francesca Nacci [Italie] ; Luigi Sinigaglia [Italie] ; Laura Bianchino [Italie] ; Roberto Caporali [Italie]Subcutaneous tocilizumab alone or with a csDMARD in rheumatoid arthritis patients: subanalysis of Italian data from a multicenter phase IIIb/IV trial.
000852 (2019) Bartosz Urbaniak [Pologne] ; Szymon Plewa [Pologne] ; Agnieszka Klupczynska [Pologne] ; Dorota Sikorska [Pologne] ; Włodzimierz Samborski [Pologne] ; Zenon J. Kokot [Pologne]Serum free amino acid levels in rheumatoid arthritis according to therapy and physical disability.
000894 (2019) Emma L. Simpson [Royaume-Uni] ; Shijie Ren [Royaume-Uni] ; Emma S. Hock [Royaume-Uni] ; John W. Stevens [Royaume-Uni] ; Aymeric Binard [France] ; Yves-Marie Pers [France] ; Rachel Archer [Royaume-Uni] ; Suzy Paisley [Royaume-Uni] ; Matthew D. Stevenson [Royaume-Uni] ; Chloé Herpin [France] ; Salah Ghabri [France]Rheumatoid arthritis treated with 6-months of first-line biologic or biosimilar therapy: an updated systematic review and network meta-analysis.
000895 (2019) Simon Galmiche [France] ; David Buob [France] ; Soraya Fellahi [France] ; Jean-Philippe Bastard [France] ; Gilles Grateau [France] ; Sophie Georgin-Lavialle [France]Rheumatoid arthritis revealed by polyadenopathy, diarrhea and digestive AA amyloidosis.
000899 (2019) Ryuki Sakaguchi [Japon] ; Keita Fujikawa [Japon] ; Momoko Okamoto [Japon] ; Emi Matsuo [Japon] ; Kohei Matsumoto [Japon] ; Tomohisa Uchida [Japon] ; Kawashiri Shin-Ya [Japon] ; Masahiro Nakashima [Japon] ; Akinari Mizokami [Japon] ; Atsushi Kawakami [Japon]Rheumatoid Arthritis Complicated with Nasal Septum Perforation Due to Methotrexate-associated Lymphoproliferative Disorder
000902 (2019) Shunsuke Mori [Japon] ; Tamami Yoshitama [Japon] ; Yasuyo Abe [Japon] ; Toshihiko Hidaka [Japon] ; Naoyuki Hirakata [Japon] ; Kiyoshi Aoyagi [Japon] ; Yukitaka Ueki [Japon]Retention of tocilizumab with and without methotrexate during maintenance therapy for rheumatoid arthritis: the ACTRA-RI cohort study.
000918 (2019) Tetsuro Yokokawa [Japon] ; Hiroyuki Kunii [Japon] ; Takashi Kaneshiro [Japon] ; Shohei Ichimura [Japon] ; Akiomi Yoshihisa [Japon] ; Makiko Yashiro Furuya [Japon] ; Tomoyuki Asano [Japon] ; Kazuhiko Nakazato [Japon] ; Takafumi Ishida [Japon] ; Kiyoshi Migita [Japon] ; Yasuchika Takeishi [Japon]Regressed coronary ostial stenosis in a young female with Takayasu arteritis: a case report.
000920 (2019) Chun-Yan Wang ; Shao-Hua Guo ; Li-Ping Wang ; Hai-Li ShenRefractory adult-onset Still disease treated by tocilizumab combined with methotrexate
000B13 (2019) Vivian P. Bykerk [États-Unis] ; Andrew J K. Östör [Australie] ; José Alvaro-Gracia [Espagne] ; Karel Pavelka [République tchèque] ; José Andrés Román Ivorra [Espagne] ; Michael T. Nurmohamed [Pays-Bas] ; Yves Luder [Suisse] ; Paris N M. Sidiropoulos [États-Unis] ; Jenny Devenport [États-Unis] ; Jean Sibilia [France]Long-term safety and effectiveness of tocilizumab in patients with rheumatoid arthritis and inadequate responses to csDMARDs and/or TNF inhibitors: an open-label study close to clinical practice.
000B65 (2019) Maxime Ma Verhoeven [Pays-Bas] ; Marjolein Jh De Hair [Pays-Bas] ; Janneke Tekstra [Pays-Bas] ; Johannes Wj Bijlsma [Pays-Bas] ; Jacob M. Van Laar [Pays-Bas] ; Attila Pethoe-Schramm [Suisse] ; Michelle Ea Borm [Pays-Bas] ; Evert-Jan Ter Borg [Pays-Bas] ; Suzanne P. Linn-Rasker [Pays-Bas] ; Xavier M. Teitsma [Pays-Bas] ; Floris Pjg Lafeber [Pays-Bas] ; Johannes Wg Jacobs [Pays-Bas] ; Paco Mj Welsing [Pays-Bas]Initiating tocilizumab, with or without methotrexate, compared with starting methotrexate with prednisone within step-up treatment strategies in early rheumatoid arthritis: an indirect comparison of effectiveness and safety of the U-Act-Early and CAMERA-II treat-to-target trials.
000C44 (2019) Vibeke Strand [États-Unis] ; Sophie Dimonaco [Royaume-Uni] ; Katie Tuckwell [États-Unis] ; Micki Klearman [États-Unis] ; Neil Collinson [Royaume-Uni] ; John H. Stone [États-Unis]Health-related quality of life in patients with giant cell arteritis treated with tocilizumab in a phase 3 randomised controlled trial.
000C57 (2019) John H. Stone ; Katie Tuckwell ; Sophie Dimonaco ; Micki Klearman ; Martin Aringer ; Daniel Blockmans ; Elisabeth Brouwer ; Maria C. Cid ; Bhaskar Dasgupta ; Juergen Rech ; Carlo Salvarani ; Hendrik Schulze-Koops ; Georg Schett ; Robert Spiera ; Sebastian H. Unizony ; Neil CollinsonGlucocorticoid Dosages and Acute‐Phase Reactant Levels at Giant Cell Arteritis Flare in a Randomized Trial of Tocilizumab
000C93 (2019) Ernest Choy [Royaume-Uni] ; Nick Freemantle [Royaume-Uni] ; Clare Proudfoot [Royaume-Uni] ; Chieh-I Chen [États-Unis] ; Laurence Pollissard [France] ; Andreas Kuznik [États-Unis] ; Hubert Van Hoogstraten [États-Unis] ; Erin Mangan [États-Unis] ; Paulo Carita [France] ; Thi-Minh-Thao Huynh [France]Evaluation of the efficacy and safety of sarilumab combination therapy in patients with rheumatoid arthritis with inadequate response to conventional disease-modifying antirheumatic drugs or tumour necrosis factor α inhibitors: systematic literature review and network meta-analyses
000D25 (2019) Ernest Choy [Royaume-Uni] ; Roberto Caporali [Italie] ; Ricardo Xavier [Brésil] ; Bruno Fautrel [France] ; Raimon Sanmarti [Espagne] ; Min Bao [États-Unis] ; Jenny Devenport [États-Unis] ; Attila Pethö-Schramm [Suisse]Effects of concomitant glucocorticoids in TOZURA, a common-framework study programme of subcutaneous tocilizumab in rheumatoid arthritis
000D67 (2019) Ryosuke Yamate [Japon] ; Takashi Matono [Japon] ; Takashi Yaguchi [Japon] ; Yusuke Fujii [Japon] ; Yuki Goto [Japon] ; Kazunori Tobino [Japon] ; Hiroshi Imura [Japon] ; Shuji Nagano [Japon]Disseminated nocardiosis with Nocardia brasiliensis bacteremia in a patient with rheumatoid arthritis using tocilizumab.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Drug Therapy, Combination" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Drug Therapy, Combination" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Drug Therapy, Combination
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021